US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
PolyPeptide Group AG (PK) (PLYGF) 銘柄情報

PolyPeptide Group AG (PK) (PLYGF)

43.00

0.00

(0.00%)

終了 6月14日 5:00AM

PolyPeptide Group AG (PK) (PLYGF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

43.00

( - )

買値

0.0101

売値

542.42

出来高

8

0.00 日の範囲 0.00

31.50 52 週間の範囲 50.00

時価総額

前日終値

43.00

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 85,086

発行済株式数

33,006,565

配当利回り

PER

-61.83

1 株当たり利益 (EPS)

-0.64

歳入

389.33M

純利益

-21.17M

PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally. It develops and manufactures synthetic peptides used as active pharmaceutical ingredients or intermediates in therapeutic products. The company offers po... PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally. It develops and manufactures synthetic peptides used as active pharmaceutical ingredients or intermediates in therapeutic products. The company offers portfolio of drug therapies for metabolic diseases, including the GLP-1. It also provides generic peptides and peptides used in cosmetics, animal health, and medical devices, as well as development and analytical services. The company serves academic, pharmaceutical, and biotech companies. PolyPeptide Group AG was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.polypeptide.com

本社

Baar, Switzerland

設立

2026

PolyPeptide Group AG (PK) is listed in the sector of the その他OTC with ticker PLYGF. The last closing price for PolyPeptide (PK) was US$43. Over the last year, PolyPeptide (PK) shares have traded in a share price range of US$ 31.50 to US$ 50.00.

PolyPeptide (PK) currently has 33,006,565 shares in issue. The market capitalisation of PolyPeptide (PK) is US$1.42 billion. PolyPeptide (PK) has a price to earnings ratio (PE ratio) of -61.83.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	43	43	43	105	43	CS
4	0	0	43	43	43	105	43	CS
12	7.61	21.5032495055	35.39	50	35.39	123	40.930316	CS
26	8.75	25.5474452555	34.25	50	31.5	175	39.33573496	CS
52	8.75	25.5474452555	34.25	50	31.5	127	38.45501889	CS
156	8.75	25.5474452555	34.25	50	31.5	127	38.45501889	CS
260	8.75	25.5474452555	34.25	50	31.5	127	38.45501889	CS

PLYGF - Frequently Asked Questions (FAQ)

What is the current PolyPeptide Group AG (PK) share price?

The current share price of PolyPeptide Group AG (PK) is US$ 43.00

How many PolyPeptide Group AG (PK) shares are in issue?

PolyPeptide Group AG (PK) has 33,006,565 shares in issue

What is the market cap of PolyPeptide Group AG (PK)?

The market capitalisation of PolyPeptide Group AG (PK) is USD 1.42B

What is the 1 year trading range for PolyPeptide Group AG (PK) share price?

PolyPeptide Group AG (PK) has traded in the range of US$ 31.50 to US$ 50.00 during the past year

What is the PE ratio of PolyPeptide Group AG (PK)?

The price to earnings ratio of PolyPeptide Group AG (PK) is -61.83

What is the cash to sales ratio of PolyPeptide Group AG (PK)?

The cash to sales ratio of PolyPeptide Group AG (PK) is 3.36

What is the registered address of PolyPeptide Group AG (PK)?

The registered address for PolyPeptide Group AG (PK) is Neuhofstrasse 24, Baar, Zug, 6340

What is the PolyPeptide Group AG (PK) website address?

The website address for PolyPeptide Group AG (PK) is www.polypeptide.com

jay_tee

jay_tee 13分前

That “yup still there” has to be the most asinine post ever. Where else would worthless paper/digital em shares be? Sure the shares are there BUT Seamus has taken its value and poured it into FOXO. He played us all well at least up to this point….safe shares sitting at .000001 is toilet paper

doogdilinger

doogdilinger 21分前

Right place at the right time BERK buddy:

joe_techi

joe_techi 32分前

The Rolling Stones - 2000 Light Years From Home
https://www.youtube.com/watch?v=RLhFT7YXnoI

xoom

Exactly. Please ask your bosses to distribute shares asap..
Please ask your bosses to learn from Musk and how he treats his folks aka SpaceX shareholders.

Frankestin

Frankestin 42分前

https://youtu.be/iH3oOVKt0WI?is=6VNcgxb-14JC0yZD

gregcod

gregcod 48分前

Is july going to be IBATs Month?

rodeoup

rodeoup 2時間前

Spot on. This will be the best summer this company has ever had in my book!!!

Dragonman1

Dragonman1 2時間前

please send me the email

satter

satter 2時間前

Unless he is going to announce he is receiving some major investment, capital, nothing is going to change. Eric will just make it sound like some big change coming with his master of loaded words. And unfortunately once again you'll fall for it. Even after Eric mislead, misrepresented, again, how gr

US Market News

US Market News 2時間前

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLLJune 14, 2026 3:15 AM
PR Newswire (US) BRUIN C

eagle8

eagle8 2時間前

Andrew Caravello, DO reposted
RJM
@rjmsoflo
The Day After Approval

Strategically Dangerous

$NWBO

What does NWBO look like to serious money the day after approval?

Because right now… the market sees OTC, delays, dilution

t1215s

t1215s 2時間前

Good morning people, There are. Others that could use that monies without a doubt for whatever their needs are , As for me ,I never really counted on it,hence my iffen on topic of returns , but I sure as heck would enjoying spending it and giving some away for sure ,as my life is just fine the way

Investor2014

Investor2014 3時間前

Terrie should go for $1249 and call it quits.

Tr8dervic

Tr8dervic 3時間前

I'm in with 5 11 24 19

Dave has 5 24 19 11

Waiting on Stephen

mrwrn2010

mrwrn2010 3時間前

“WHEREAS, Elite Laboratories, Inc., intends to amend ANDA No. 217939…”

I take that to mean they are just flipping to P3 and not starting from scratch. Question is how much review has the FDA done on this ANDA to date? And does the 30-month stay only affect final approval, or does it b

europa7

europa7 4時間前

Dell Technologies to Bring Grok SpaceXAI Models On-Premises to Enterprise Environments
"...Dell and SpaceXAI bring Grok AI models on-premises, giving enterprises advanced AI with complete data control and security..."
May 18, 2026
https://www.dell.com/en-us/blog/dell-technologie

Just give me $1.50

Just give me $1.50 4時間前

Does anybody know the answer to this question?

1. Does Elite have to submit a brand new Paragraph 3 filing for Generic OxyContin, meaning they'll have to wait the full 10 months for a Tentative Approval. Or can we just switch it from Paragraph 4 to Paragraph 3 with someone paperwor

Just give me $1.50

Just give me $1.50 4時間前

1. How do you know that isn't standard boilerplate language? In other words, every company in the same/similar situation does the exact same thing. Similar to 10-K's for publicly traded companies, literally every possible scenario and warning is listed in there.

2. What are the

barnstormer

barnstormer 4時間前

082, if she had ever said that there would be a record somewhere on file. You're good at making up supposed statements but as usual when pushed for support of your statement there isn't anything to be found. That's pretty par for the course with your act. Make up a story or accusation without suppor

europa7

europa7 4時間前

Dell’s $10b DoD Deal Adds Support To AI Infrastructure Story
June 3, 2026
https://finance.yahoo.com/markets/stocks/articles/dell-10b-dod-deal-adds-070959172.html
***
***
Pentagon Deal Triggers Speculation — Could Dell Bring Hedera Into Federal Systems?
30 Ma

norisknorewards

norisknorewards 4時間前

What a great post with an overload of common sense!!!!

Go NWBO!!!

JD400

JD400 4時間前

Ross Coulthart reviews 'Disclosure Day' | Reality Check with Ross Coulthart

Premiered 4 hours ago Reality Check with Ross Coulthart
As the world packs theaters to watch Steven Spielberg's newest UFO film, real-world disclosure is happening in real time. NewsNation and Ross Co

sam1933

sam1933 4時間前

The next trillion transactions won’t come from humans.

They’ll come from satellites, sensors, machines, and AI agents interacting autonomously.

https://x.com/CreusMoreira/status/2064583073526616219

JD400

JD400 4時間前

Ross Coulthart reviews 'Disclosure Day' | Reality Check with Ross Coulthart

Premiered 4 hours ago Reality Check with Ross Coulthart
As the world packs theaters to watch Steven Spielberg's newest UFO film, real-world disclosure is happening in real time. NewsNation and Ross Co

PolyPeptide (PK)

Mirage Energy (EM)

Phillips Hager & North C...

D1000 Varejo Farma Parti... ON

Western Forest Products

iShares Lifepath Target ...

Domestic bond 2.875% 13a...

Australian Vanadium

Dorsey Wright Financials...

OMX Baltic Basic Resourc...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。